Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome. (scientific article)

Right ventricular outflow tract dimensions in arrhythmogenic right ventricular cardiomyopathy/dysplasia-a multicentre study comparing echocardiography and cardiovascular magnetic resonance.

Q50855137

How to measure the right ventricular outflow tract with cardiovascular magnetic resonance imaging: a head-to-head comparison of methods.

Q51098727

Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.

Q51204140

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

Q55638651

Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging

Q82690026

Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium

Q83609756

Echocardiographic tissue deformation imaging quantifies abnormal regional right ventricular function in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Q84121874

Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation

Q85936811

Atlas of the clinical genetics of human dilated cardiomyopathy

Q28246768

Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

Q28294931

Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype

Q28304358

Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis

Q28585881

Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy

Q33151484

Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome

Q33153396

Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome

Q33156672

SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome

Q33158197

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.

Q33160801

Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology,

Q34125322

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

Q34232976

SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility

Q34372532

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Q34465792

Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Q35531136

Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients

Q35674798

Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.

Q36245208

Simultaneous Non-Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms

Q37556015

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Q38134931

Brugada syndrome: a heterogeneous disease with a common ECG phenotype?

Q38176956

Late gadolinium enhancement in Brugada syndrome: A marker for subtle underlying cardiomyopathy?

Q38407903

Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: Potential diagnostic and prognostic implications

Q39320655

Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study.

Q40355175

Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome

Q42912081

The Australian Genetic Heart Disease Registry

Q44223320

Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome

Q44436850

Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.

Q46317627

Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities.

Q46634056

P275